Pineridge Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19
Closed -$3.34K 570
2025
Q2
$3.34K Hold
19
﹤0.01% 357
2025
Q1
$2.56K Buy
19
+6
+46% +$790 ﹤0.01% 389
2024
Q4
$1.64K Hold
13
﹤0.01% 500
2024
Q3
$2.16K Hold
13
﹤0.01% 443
2024
Q2
$1.73K Hold
13
﹤0.01% 492
2024
Q1
$1.37K Sell
13
-22
-63% -$1.98K ﹤0.01% 492
2023
Q4
$2.65K Buy
+35
New +$2.22K ﹤0.01% 594

Other funds holding THC

Pineridge Advisors's THC Position: Q3 2025 in Review

Pineridge Advisors sold out of Tenet Healthcare (THC) in Q3 2025, closing a stake of 19 shares — an estimated $3.34K sold.

Pineridge Advisors first reported a position in THC in Q4 2023 and held it in 7 quarters. The position peaked at $3.34K in Q2 2025. 680 funds tracked by Wall St. Rank hold THC as of Q3 2025.

  • Pineridge Advisors reported no remaining Tenet Healthcare position as of Q3 2025 after selling out during the quarter.
  • Pineridge Advisors sold 19 Tenet Healthcare shares in Q3 2025, an estimated $3.34K.
  • Pineridge Advisors first reported a position in Tenet Healthcare in Q4 2023 and held it in 7 quarters.
  • Pineridge Advisors's Tenet Healthcare position peaked at $3.34K in Q2 2025.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.